RankingsPricing
  1. JP-listed companies
  2. ZERIA PHARMCEUTICAL CO., LTD.
  3. Financials
  4. Earnings per share

ZERIA PHARMCEUTICAL CO., LTD.【JP:4559】

Market cap
¥112.2B
P/E ratio
9.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025225.4+28.53%
Mar 31, 2024175.4+25.05%
Mar 31, 2023140.3+59.82%
Mar 31, 202287.8+29.59%
Mar 31, 202167.7+8.14%
Mar 31, 202062.6-9.98%
Mar 31, 201969.6-13.83%
Mar 31, 201880.7+20.97%
Mar 31, 201766.7+0.88%
Mar 31, 201666.2+37.38%
Mar 31, 201548.2-58.13%
Mar 31, 2014115+31.33%
Mar 31, 201387.6+26.56%
Mar 31, 201269.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)